Heparanase: A key enzyme involved in cell invasion

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1471, Issue 3, 2001, Pages

  Parish, Christopher R ^a   Freeman, Craig ^a   Hulett, Mark D ^a  

^a Biology and Environment   (Australia)

Author keywords

Angiogenesis; Cell invasion; Endoglycosidase; Extracellular matrix; Heparan sulfate; Heparanase; Metastasis

Indexed keywords

GLYCOSAMINOGLYCAN; GLYCOSIDASE; GROWTH FACTOR; HEPARAN SULFATE; HEPARANASE; N ACETYL BETA GLUCOSAMINIDASE;

ANGIOGENESIS; CATALYSIS; CELL INVASION; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; METASTASIS; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; WOUND HEALING;

EID: 0035091164     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(01)00017-8     Document Type: Review

References (50)

1. Molecular architecture of basement membrane
2. Proteoglycans: Structures and interactions
3. The coordinated regulation of heparan sulfate, syndecans and cell behavior
4. Growth factors in the extracellular matrix
5. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor
6. Proteases as prognostic markers in cancer
7. Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation
8. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix
9. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix
10. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype
11. A heparan sulfate-degrading endoglycosidase from rat liver tissue
12. Purification and properties of human platelet heparitinase
13. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes
14. Human platelet heparanase: Purification, characterization and catalytic activity
15. Tumor rejection antigens of the hsp90 family (gp96) closely resemble tumor-associated heparanase enzymes
16. A rapid quantitative assay for the detection of mammalian heparanase activity
17. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
18. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
19. Cloning and functional expression of a human heparanase gene
20. Human heparanase. Purification, characterization, cloning, and expression
21. Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer
22. Heparanase expression in invasive trophoblasts and acute vascular damage
23. Human HPA endoglycosidase heparanase. Map position 4q21.3
24. Genomic organization and chromosome localization of the newly identified human heparanase gene
25. Identification of active site residues of the pro-metastatic endoglycosidase heparanase
26. Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member
27. Heparan sulphate degradation relation to tumour invasive and metastatic properties of mouse B16 melanoma sublines
28. Lymphoma cell mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: Relation to tumour cell metastasis
29. Mammalian heparanase as mediator of tumor metastasis and angiogenesis
30. Expression of heparanase in normal, dysplastic and neoplastic human colon mucosa and stroma
31. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
32. Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: Evidence for cytokine dependence and detection of a novel sulfatase
33. Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase
34. Treatment of central nervous system inflammation with inhibitors of basement membrane degradation
35. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation
36. Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo
37. Analysis of the inhibition of tumour metastasis by sulphated polysaccharides
38. Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanase
39. Chemically modified heparins as inhibitors of heparan sulfate specific endo-β-glucuronidase (heparanase) of metastatic melanoma cells
40. Inhibition of tumor metastasis by heparanase inhibiting species of heparin
41. Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells
42. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides
43. Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis
44. Suramin. A potent inhibitor of melanoma heparanase
45. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity
46. Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route
47. Membrane proteases: Roles in tissue remodeling and tumour invasion
48. Evidence that platelet and tumour heparanases are similar enzymes
49. Differential effects of the anti-inflammatory compounds heparin, mannose-6-phosphate and castanospermine on degradation of the vascular basement membrane by leukocytes, endothelial cells and platelets